4 minute read
App Reviews
Genome canada unveils new Genomics
innovation network
Advertisement
The way genomics research is conducted in Canada is about to undergo a change, as Genome Canada says it is restructuring and creating a new Genomics Innovation Network.
The new network will be comprised of 10 “nodes,” each receiving core operational funding from Genome Canada, with matching funds from various public and private sector partners.
A total of $15.5 million in federal funding through Genome Canada is the initial investment being made in core operation funding for the nodes, with each receiving from $800,000 to $2 million in federal funds over two-years. Co-funding investments in the Nodes from other partners, including provincial governments, academic institutions, and the private sector at a required minimum one-to-one ratio, bring the total initial investment in the Genomics Innovation Network to approximately $31 million. The node selection process was the result of a competitive process involving peer review by an international review committee.
Under the old model, Genome Canada was making its investments in five science and technology innovation centres. Often, the five centres were “working in their own silos.” For this reason, Genome Canada president and CEO Dr. Pierre Meullien says the new network model will place greater emphasis on collaboration and the sharing of expertise among the centres. He adds that creating the Genomics Innovation Network will contribute to Canadian leadership in the development of new genomic technologies and better fulfilling this mandate.
“Breakthroughs across all sectors that form part of Canada’s growing bioeconomy – health, agriculture, fisheries and aquaculture, forestry, energy and mining – rely on researchers across Canada having access to leading-edge ‘omics technologies, which are rapidly evolving,” says Meullien. “Moreover, we want to build on past successes where we’ve seen new genomics technology development become the foundation for Canadian business growth.”
He adds that the investment will also support important work in the area of bioinformatics and computational biology, including addressing major challenges associated with the storage and analysis of “big data.” Each node will also provide Canadian and international researchers with access to the leading-edge technologies required for research in genomics, metabolomics, proteomics and related areas.
The nodes will include: The Proteomics Centre and the Sequencing Platform at the BC Cancer Agency Genome Sciences Centre, both led by Genome British Columbia; The Metabolomics Innovation Centre led by Genome Alberta; the Toronto Centre for Phenogenomics, the Network Biology Collaborative Centre, and The Centre for Applied Genomics, each led by the Ontario Genomics Institute; and the Canadian Centre for Computational Genomics, McGill University and the Génome Quebéc Innovation Centre, the Canadian Data Integration Centre, and the Centre for Advanced Proteomics Analyses, each led by Genome Quebéc.
aPP review
By: Aseptika http://www.activ8rlives.com/software/smartphone-apps.html https://itunes.apple.com/us/app/activ8rlives-3.0-health-monitoring/ id570252701?mt=8
Made for iOS and Android, the third generation Activ8rlives Health and Food Diary tracking app is a well-being solution that enables users to quickly understand where a health tracker or vital sign should be to indicate good health. The user interface is brighter, cleaner and easier to navigate. Detailed help, instruction wizards and embedded instructions are available within the App on every screen. The App also works with a full range of consumer and medical devices. Data is stored and can be shared with family supporters or carers online. Those who wish can also share their data with their medical staff using a dedicated clinician’s portal. The restructuring of the App is in preparation for CE marking as a certified medical device (initially Class 1). Data generated by the user and stored within Activ8rlives can then be accepted by clinicians world-wide and used in partnership with their patients in support of self-management programmes.
RefME
RefME is an app and online tool that crowdsources information to make the process of referencing work fully automated. The app, which is available on iPhone, Android and the Google Chrome webstore, automatically generates academic references in more than 7,000 different formats, including Harvard, APA and MLA. RefME automates the whole referencing process for you. You can search by book/journal article title, DOI, ISBN, ISSN or simply copy and paste any website URL to create a reference in seconds. Essentially, its referencing made easy. Users only need to point their smartphone camera at the barcode of a weighty academic tome and the app will present a bibliography-ready reference. All references are stored in the cloud and can be accessed online through the website and across devices. The app also pulls its data from Google Books. You can import and export your work to Microsoft Word, Evernote, Mendeley and many more applications.
Highly Evolved
The advanced control station
The BioFlo® 320 is the next generation in bioprocess control. Designed as a universal platform, the BioFlo 320 is capable of meeting the ever-changing needs of scientists in the biotech and pharmaceutical industries. The BioFlo 320 has the right combination of features to get the job done. > Universal gas control strategy for both microbial and cell culture applications > Multi-unit control of up to eight systems from a single interface > Direct integration of digital Mettler
Toledo® ISM sensor connectivity > Built-in optical pH sensing technology for use with BioBLU® vessels
